Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Gel Enema for Post-Hemorrhoid Banding Pain
NCT03797703Phase 1Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Nov 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lidocaine 10% oropharyngeal spray in Hemorrhoids (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Change in Pain following Procedure at 48 hours. Started Nov 2018; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT03797703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03797703.